CS 1544-0975
Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
TEL 033-435-4962
bgn4@bifido.com
ContactGet in touch helps us to
understand you better
| ADDRESS | 23-16, Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea |
|---|---|
| TEL | + 82-33-435-4962 |
| FAX | + 82-33-435-4963 |
| bgn4@bifido.com |
| ADDRESS | Room 916, Blue zone,150, Jojeong-daero, Hanam-si, Gyeonggi-do, Republic of Korea |
|---|---|
| TEL | + 82-31-8027-8941 |
| FAX | + 82-31-8027-8946 |
| bgn4@bifido.com |
| ADDRESS | 3rd floor, 639, Seolleung-ro, Gangnam-gu, Seoul, Republic of Korea |
|---|---|
| TEL | + 82-2-543-5196 |
| FAX | + 82-70-7545-0189 |
| bgn4@bifido.com |
| ADDRESS | Room 1005, Building No.1, No.7001 Zhongchun Road, MinhangDistrict, 201101 Shanghai China |
|---|---|
| TEL | +86-21-54718163 |
| bgn4@bifido.com |
Accrued Bioinformatics
Through Decades
| 공시제목 | 제출일자 |
|---|---|
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(높은 EPS 분비능을 보이는 와이셀라 컨푸사 VP30 및 이로부터 발효된 발효물을 포함하는 변비 개선용 식품 조성물) | 2021-10-06 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(비피도박테리움 롱검 RAPO(KTCT13773BP)를 포함하는 암 예방 또는 치료용 조성물) | 2021-09-27 |
| Change of The Largest Shareholder | 2021-09-14 |
| [Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-09-14 |
| Change of CEO | 2021-09-14 |
| Outcomes of Extraordinary General Meeting of Shareholders | 2021-09-14 |
| [Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-09-10 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 RAPO 균주 및 이를 포함하는 조성물) | 2021-09-02 |
| [Revised]Resolutions for Convocation of General Meeting of Shareholders | 2021-08-30 |
| Resolutions for Convocation of General Meeting of Shareholders | 2021-08-04 |
| [Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-07-23 |
| Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder | 2021-07-21 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(부티릴 프락토올리고당을 포함하는 프리바이오틱스 조성물) | 2021-06-16 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스관절염 개선, 예방 또는 치료를 위한 락토바실러스 가세리 HHuMin-R 균주 및 이를 포함하는 조성물) | 2021-06-08 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스 관절염 개선, 예방 또는 치료를 위한 비피도박테리움 슈도카테눌라툼 C-RAPO 균주 및 이를 포함하는 조성물) | 2021-06-07 |
| Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(비피도박테리움 비피덤을 이용한 인간 EGF 단백질의 생산방법 및 이를 함유하는 조성물) | 2021-05-13 |
| Additional Listing(무상증자) | 2021-04-20 |
| Ex-Rights(무상증자) | 2021-03-31 |
| Outcomes of Annual Meeting of Shareholders | 2021-03-26 |
| Submission of Audit Report | 2021-03-18 |